Cíntia J. Monteiro

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Sasagu Kurozumi, Mansour Alsaleem, Cíntia J. Monteiro et al. · Breast Cancer Research · 2020 · 51 citations · Full text

Medicine, Bioinformatics, Oncology +13

Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung

Alejandro Nieto‐Orellana, Huiqi Li, Rémi Rosière et al. · Journal of Controlled Release · 2019 · 33 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +14

Mir-190b negatively contributes to the Trypanosoma cruzi- infected cell survival by repressing PTEN protein expression

Cíntia J. Monteiro, Suianne Letícia Antunes Mota, Lívia de Figueiredo Diniz et al. · Memórias do Instituto Oswaldo Cruz · 2015 · 19 citations · Full text

Life Sciences, Cell Biology, Infectious Diseases +17

Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer

Patricia Monteiro, Muhammad Gulfam, Cíntia J. Monteiro et al. · Journal of Controlled Release · 2020 · 17 citations · Full text

Natural Sciences, Materials Science, Oncology +16

Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms

Kumiko Koibuchi Sakane, Cíntia J. Monteiro, Walmir da Silva et al. · Brazilian Journal of Medical and Biological Research · 2013 · 13 citations · Full text

Medicine, Cardiology, Pharmacology +13